- Global Pharma News & Resources

Press Releases - 2019-05-03

Date Title Company
03-May-2019 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics, Inc.
03-May-2019 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics, Inc.
03-May-2019 Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 Palatin Technologies, Inc.
03-May-2019 DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results DURECT Corporation
03-May-2019 Upsher-Smith Unveils Educational Resources And Support Tools For Migraine Patients Upsher-Smith Laboratories, LLC
03-May-2019 Immunicom to Present at Immuno-Oncology Investment Conference During ASCO Immunicom, Inc.
03-May-2019 MEDI FUTURES Signs MOU with Soonchunhyang University Hospital Bucheon for Clinical Research Born2Global Centre
03-May-2019 Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Allergan plc
03-May-2019 Biohaven Announces Late-Breaking Oral Presentation Of Rimegepant Zydis® ODT Phase 3 Results At American Academy Of Neurology (AAN) 2019 Annual Meeting And New Data Release At Investor Event Biohaven Pharmaceutical Holding Company Ltd.
03-May-2019 Micro-Sphere announces partnership with PTM Consulting Micro-Sphere
03-May-2019 Visiongain Report Analyses Leading Players Within the $1.6bn Bioreactors Market Visiongain
03-May-2019 Probiotics Market Worth US$74.69 Bn at 7.3% CAGR by 2025| Exclusive Report by Fortune Business Insights Fortune Business Insights
03-May-2019 New combination treatment for metastatic lung cancer patients approved for use on the NHS in England and Wales Roche
03-May-2019 Epigenomics AG: CMS accepts Epigenomics' application for NCD review Epigenomics AG
03-May-2019 Asklepios Kliniken: Solid results in a challenging 2018 financial year Asklepios Kliniken
03-May-2019 RHÖN-KLINIKUM AG Closes First Quarter 2019 with Pleasing Revenues and Earnings and Confirms its Guidance for 2019 RHÖN-KLINIKUM AG
03-May-2019 Glenmark Therapeutics Expands Specialty Portfolio With OTIPRIO® Co-Promotion Agreement in the U.S. With Otonomy for Acute Otitis Externa Indication Glenmark Pharmaceuticals Ltd
03-May-2019 Natera Announces First Quarter 2019 Earnings Conference Call Natera